Monitoring the Session

HB 4783

VanDeaver Opioid Bill Delivers A Report And Nothing Else

Became law, effective Sep 1, 2025

Verdict: Smells

SmellsReviewed
Rep. Gary VanDeaverRHouse 1
Why it's charged
Study, task force, commission, report

THE TEXT

“Not later than October 1 of each even-numbered year, the”…

Bill text, introduced version (I)

The only operative duty is a recurring report with goals and recommendations, so any real action on overdoses waits for later decisions. The caption honestly says this is a report bill.

Study, task force, commission, report

Reviewed · Nov 1, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade

Caption

relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

Caption from analyzed text · version I.

Summary

No new drug supply, money or mandate. Goals and recommendations, due October 1 of even years.

This bill orders the state health commission to write a report every two years, due October 1 of even-numbered years, on how opioid overdose reversal drugs are handed out in Texas. The report goes to the governor, the lieutenant governor and the House speaker, and the commission must consult the agencies, colleges and local governments that already get money from the existing opioid antagonist program. Nothing changes on the ground beyond the paperwork: no new drug supply, no new money and no new mandate, only goals, strategies and recommendations on paper.

Receipt

The receipt

89R-HB4783 · 2025-03-13

SOLD BY

ITEM

relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

WHAT IT DOES

No new drug supply, money or mandate. Goals and recommendations, due October 1 of even years.

This bill orders the state health commission to write a report every two years, due October 1 of even-numbered years, on how opioid overdose reversal drugs are handed out in Texas. The report goes to the governor, the lieutenant governor and the House speaker, and the commission must consult the agencies, colleges and local governments that already get money from the existing opioid antagonist program. Nothing changes on the ground beyond the paperwork: no new drug supply, no new money and no new mandate, only goals, strategies and recommendations on paper.

CHARGES

[x] STUDY, TASK FORCE, COMMISSION, REPORTanalysis confidence 50%

THE TEXT

“Not later than October 1 of each even-numbered year, the”…

Bill text, introduced version (I)

The only operative duty is a recurring report with goals and recommendations, so any real action on overdoses waits for later decisions. The caption honestly says this is a report bill.

TOTAL

No significant fiscal implication to the State is anticipated.

LBB estimate · fiscal note version F · source

Sources

Fiscal note · version F · May 21, 2025

No first-year general revenue figure available here.

LBB published estimates · flow over the stated periods.

Source snapshot 2026-10-19, Central time.

HISTORY

  1. Filed
  2. Read first time
  3. Referred to Public Health
  4. Scheduled for public hearing on . . .
  5. Considered in public hearing
  6. Testimony taken/registration(s) recorded in committee
  7. Left pending in committee
  8. Considered in formal meeting
  9. Reported favorably w/o amendment(s)
  10. Comte report filed with Committee Coordinator
  11. Committee report distributed
  12. Committee report sent to Calendars
  13. Considered in Calendars
  14. Placed on General State Calendar
  15. Read 2nd time
  16. Passed to engrossment
  17. Read 3rd time
  18. Passed
  19. Record vote RV#1429
  20. Statement(s) of vote recorded in Journal
  21. Reported engrossed
  22. Received from the House
  23. Read first time
  24. Referred to Health & Human Services
  25. Scheduled for public hearing on . . .
  26. Considered in public hearing
  27. Testimony taken in committee
  28. Left pending in committee
  29. Considered in public hearing
  30. Vote taken in committee
  31. Reported favorably as substituted
  32. Recommended for local & uncontested calendar
  33. Committee report printed and distributed
  34. Co-sponsor authorized
  35. Placed on intent calendar
  36. Rules suspended-Regular order of business
  37. Vote recorded in Journal
  38. Read 2nd time & passed to 3rd reading
  39. Vote recorded in Journal
  40. Three day rule suspended
  41. Record vote
  42. Read 3rd time
  43. Passed
  44. Record vote
  45. Senate passage as amended reported
  46. Senate Amendments distributed
  47. Senate Amendments Analysis distributed
  48. House concurs in Senate amendment(s)
  49. Record vote RV#3438
  50. Statement(s) of vote recorded in Journal
  51. Text of Senate Amendment(s)
  52. House concurs in Senate amendment(s)-reported
  53. Reported enrolled
  54. Signed in the House
  55. Signed in the Senate
  56. Sent to the Governor
  57. Signed by the Governor
  58. Effective on 9/1/25
FILED UNDER

No verified beat found.

SIGNED FOR BY

House · 137 yea · 10 nay

Senate · 30 yea · 1 nay

Sources

House: Final passage · May 6, 2025. Journal. Published stock for this vote. Snapshot 2026-10-19, Central time.

Senate: Final passage · May 20, 2025. Journal. Published stock for this vote. Snapshot 2026-10-19, Central time.

All floor motions and other positions below.

Smells

THANK YOU FOR CHECKING THE RECEIPT

CAMPAIGN PAID FOR BY

CAMPAIGN PAID FOR BY

Donors

Texans for Lawsuit Reform PAC Austin TX$15,000
HEB PAC San Antonio TX$5,000
Jason Itkin Arnold Itkin Houston TX$5,000

Derived from itemized gifts, Jul 1, 2024 to Jun 30, 2026. State data as of Nov 4, 2026.

Not tied to this bill.

Sources

The author's campaign account only. Own money and internal transfers are separate on the member page.

$67,121 raised in 4 of 4 reports since Jul 1, 2024. Derived sum of published report totals. Flow, Jul 1, 2024 through Jun 30, 2026. State filing data as of Nov 4, 2026. 4 of 4 filed reports carry a published figure. Partial total. Regular reports do not cover Aug 15, 2025 to Sep 4, 2025.

$104,472 spent since Jul 1, 2024. Derived sum of published report totals. Flow, Jul 1, 2024 through Jun 30, 2026. State filing data as of Nov 4, 2026. 4 of 4 filed reports carry a published figure.

$35,071 cash on hand. Published report total. Stock, as of Jun 30, 2026. State filing data as of Nov 4, 2026.

$0 loans outstanding. Published report total. Stock, as of Jun 30, 2026. State filing data as of Nov 4, 2026.

Derived sum of itemized contributions in regular reports and uncovered special-session dates. Unitemized contributions are not included. Flow, Jul 1, 2024 through Jun 30, 2026. State filing data as of Nov 4, 2026.

Money

Missing data does not establish zero giving. Display amounts are rounded.

Votes5

House May 23, 2025

Yea
112
Nay
24
Present, not voting
1
Absent
6
Excused
7
Names

Named positions matched to lawmakers. See the journal for unmatched names.

House journal

Sources

Record 3438

Representative VanDeaver moved to concur in the senate amendments to HB 4783. The motion to concur in the senate amendments to HB 4783 prevailed by (Record 3438): 112 Yeas, 24 Nays, 1 Present, not voting.

Published stock of positions for this vote, except where marked derived.

  • Yea: 112 (published)
  • Nay: 24 (published)
  • Present, not voting: 1 (published)
  • Absent: 6 (derived from named list)
  • Excused: 7 (derived from named list)

House journal. Source snapshot 2026-10-19, Central time.

Senate May 20, 2025

Yea
30
Nay
1
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Named positions matched to lawmakers. See the journal for unmatched names.

Senate journal

Names were not printed for yea. Only the named positions are included in member records.

Sources

The bill was read third time and was passed by the following vote: Yeas 30, Nays 1. (Same as previous roll call)

Published stock of positions for this vote, except where marked derived.

  • Yea: 30 (published)
  • Nay: 1 (published)
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

Senate May 20, 2025

Yea
30
Nay
1
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Named positions matched to lawmakers. See the journal for unmatched names.

Senate journal

Names were not printed for yea. Only the named positions are included in member records.

Sources

Senator Hancock moved that Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that CSHB 4783 be placed on its third reading and final passage. The motion prevailed by the following vote: Yeas 30, Nays 1.

Published stock of positions for this vote, except where marked derived.

  • Yea: 30 (published)
  • Nay: 1 (published)
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

Senate May 20, 2025

Yea
Not printed
Nay
Not printed
Present, not voting
Not printed
Absent
Not printed
Excused
Not printed
Names

Named positions matched to lawmakers. See the journal for unmatched names.

Senate journal

Names were not printed for yea. Only the named positions are included in member records.

Voice vote. No numeric tally or individual yeas are inferred.

Sources

Senator Hancock moved to suspend the regular order of business to take up for consideration CSHB 4783 at this time on its second reading: CSHB 4783, Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses. The motion prevailed. Senator Hagenbuch asked to be recorded as voting "Nay" on suspension of the regular order of business. The bill was read second time and was passed to third reading by a viva voce vote.

Published stock of positions for this vote, except where marked derived.

  • Yea: Not printed
  • Nay: Not printed
  • Present, not voting: Not printed
  • Absent: Not printed
  • Excused: Not printed

Senate journal. Source snapshot 2026-10-19, Central time.

House May 6, 2025

Yea
137
Nay
10
Present, not voting
1
Absent
2
Excused
0
Names

Named positions matched to lawmakers. See the journal for unmatched names.

House journal

Sources

Record 1429

HB 4783 was passed by (Record 1429): 137 Yeas, 10 Nays, 1 Present, not voting.

Published stock of positions for this vote, except where marked derived.

  • Yea: 137 (published)
  • Nay: 10 (published)
  • Present, not voting: 1 (published)
  • Absent: 2 (derived from named list)
  • Excused: 0 (derived from named list)

House journal. Source snapshot 2026-10-19, Central time.

Witnesses26
For
25
Against
0
On
1
Names

For

  • Assoc of Substance Abuse Programs & Texas Recovery Network1 registration
  • City of Dallas2 registrations
  • DHR Health1 registration
  • Methodist Healthcare Ministries2 registrations
  • NAMI Texas2 registrations
  • Self3 registrations
  • Self; Assoc of Substance Abuse Programs, Tx Assoc of Addiction Professionals, La Hacienda Treatment Center1 registration
  • Self; Cannabis Reform of Texas1 registration
  • Self; RecoveryPeople and Texas Coalition for Healthy Minds1 registration
  • Texas Chapter American College of Physicians2 registrations
  • Texas Council of Community Centers2 registrations
  • Texas Hospital Association2 registrations
  • Texas medical assn1 registration
  • Texas Pediatric Society2 registrations
  • The National Association of Social Workers- Texas Chapter1 registration
  • Travis County Commissioners Court1 registration

On

  • HHSC1 registration
Sources

26 parsed registrations across the loaded witness lists.

Derived stock of witness registrations. Repeated appearances count separately. Organizations and self-representation appear as printed.

House witness list. Source snapshot 2026-10-20, Central time.

Senate witness list. Source snapshot 2026-10-20, Central time.

Fiscal

No significant fiscal implication to the State is anticipated.

LBB estimate · fiscal note version F · source

Sources

Fiscal note · version F · May 21, 2025

No first-year general revenue figure available here.

LBB published estimates · flow over the stated periods.

Source snapshot 2026-10-19, Central time.

How this was graded

Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.

Sources

Texas House · Filed Mar 13, 2025

06/20/2025 E Effective on 9/1/25

Texas Legislature Online · Introduced · House Committee Report · Engrossed · Senate Committee Report · Enrolled

Data snapshot Nov 1, 2026 at 3:12 PM CST. Grades, charges, quotes and corrections follow the published record.

Sponsors
Cosponsors

House committee · Public Health · Committee vote 11 aye, 0 nay, 2 absent · Out of committee

Senate committee · Health & Human Services · Committee vote 8 aye, 0 nay, 1 absent · Out of committee

Companion

SB 2378 by Hancock (similar)

Subjects

Alcoholism & Drug Abuse

Crimes--Drugs

State Agencies, Boards & Commissions

MEDICINE & PRESCRIPTION DRUGS

HEALTH & HUMAN SERVICES COMMISSION

Text

The text as introduced · 338 words

89R9017 AB-D

By: VanDeaver
H.B. No. 4783

A BILL TO BE ENTITLED

AN ACT

relating to a report on governmental opioid antagonist programs to

reverse and prevent opioid overdoses.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Subchapter B, Chapter 461A, Health and Safety

Code, is amended by adding Section 461A.060 to read as follows:

Sec. 461A.060. BIENNIAL REPORT ON OPIOID ANTAGONIST

PROGRAMS FOR OPIOID OVERDOSE REVERSAL AND PREVENTION. (a) In this

section, "opioid antagonist" has the meaning assigned by Section

483.101.

(b) Not later than October 1 of each even-numbered year, the

commission shall:

(1) prepare a report evaluating the distribution of

opioid antagonists in this state to reverse and prevent opioid

overdoses; and

(2) submit the report to the governor, the lieutenant

governor, and the speaker of the house of representatives.

(c) The report described by Subsection (b) must:

(1) include a needs assessment for the opioid

antagonist program established under Section 461A.059;

(2) establish a statewide saturation goal for opioid

antagonists and include:

(A) a description of the data sources and

methodology used to estimate insufficiencies in the current supply

of opioid antagonists; and

(B) a communications plan to address opioid

overdoses in areas of this state at higher risk for increased

numbers of overdoses;

(3) include a description of all state and federal

money appropriated to the opioid antagonist program established

under Section 461A.059;

(4) establish opioid antagonist distribution

strategies for this state;

(5) list and describe all available state and

federally funded purchase and distribution programs for opioid

antagonists; and

(6) recommend improvements for addressing opioid

overdoses among high-risk populations, including school-aged

children, pregnant and postpartum women, and individuals residing

in rural areas of this state.

(d) In preparing the report under this section, the

commission shall coordinate and consult with each state agency,

institution of higher education, and political subdivision of this

state that receives funding or other resources under Section

461A.059 for the distribution of opioid antagonists.

SECTION 2. This Act takes effect September 1, 2025.